Highlights and Financial Summary
(Unaudited, revenue growth in constant currencies)
On a non-IFRS basis: Q3 EPS of €0.80 at high end and Operating Margin of 28.2% above target
Non-IFRS organic recurring revenue up 4% in Q3 and YTD
Mainstream Innovation non-IFRS software revenue up 9% in Q3
3DEXPERIENCE non-IFRS software revenue up 6% in Q3
Medidata delivers double-digit non-IFRS revenue growth on a comparable basis in Q3 and YTD
YTD cash flow from operations at €1 billion, stable with year-ago quarter
Confirming 2020 non-IFRS EPS of €3.70 to €3.75, up 3% to 5% in constant currencies